Synthesis of antisense oligonucleotides containing 2′-O-psoralenylmethoxyalkyl adenosine for photodynamic regulation of point mutations in RNA

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 2, 2009, Pages 475-483

  Higuchi, Maiko ^a   Kobori, Akio ^a   Yamayoshi, Asako ^a   Murakami, Akira ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Photo cross linking; Photodynamic antisense therapy; Point mutation; Psoralen

Indexed keywords

ADENOSINE DERIVATIVE; ALKYL GROUP; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGORIBONUCLEOTIDE; PSORALEN DERIVATIVE; RNA;

ARTICLE; BASE PAIRING; CONJUGATION; CROSS LINKING; DRUG SELECTIVITY; DRUG SYNTHESIS; GENE SEQUENCE; MOLECULAR RECOGNITION; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; POINT MUTATION; THERMOSTABILITY; ULTRAVIOLET A RADIATION;

ADENOSINE; BINDING SITES; CROSS-LINKING REAGENTS; OLIGONUCLEOTIDES, ANTISENSE; PHOTOCHEMISTRY; POINT MUTATION; PSORALENS; RNA, MESSENGER;

EID: 58549088493     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.12.001     Document Type: Article

References (34)

1. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. Science 253 (1991) 49
2. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. Cancer Res. 54 (1994) 4855
3. Wolf D.M., and Jordan V.C. Breast Cancer Res. Treat. 31 (1994) 129
4. England G.M., Bilimoria M.M., Chen Z., Assikis V.J., Muenzner H.D., and Jordan V.C. Int. J. Oncol. 12 (1998) 981
5. Barbacid M. Annu. Rev. Biochem. 56 (1987) 779
6. Johannes L.B., Fearon E.R., and Hamilton S.R. Nature 327 (1987) 293
7. Kahn S., Yamamoto F., Almoguera C., Winter E., Forrester K., Jordano J., and Perucho M. Anticancer Res. 7 (1987) 639
8. Johannes L.B. Cancer Res. 49 (1989) 4682
9. Kurreck J. Eur. J. Biochem. 270 (2003) 1628
10. Manoharan M. Biochem. Biophys. Acta 1489 (1999) 117
11. Vester B., and Wengel J. Biochemistry 43 (2004) 13233
12. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., and Tuschl T. EMBO J. 23 (2001) 6877
13. Amarzguioui M., Holen T., Babaie E., and Prydz H. Nucleic Acids Res. 31 (2003) 589
14. Braasch D.A., Jensen S., Liu Y., Kaur K., Arar K., White M.A., and Corey D.R. Biochemistry 42 (2003) 7967
15. Chang E.C., Miller P.S., Cushman C., Devadas K., Pirollo K.F., Ts′o P.O.P., and Yu Z.P. Biochemistry 30 (1991) 8283
16. Mukhopadhyay T., Tainsky M., Cavender A.C., and Roth J.A. Cancer Res. 51 (1991) 1744
17. Zhang Y., Mukhopadhyay T., Donehower L.A., George R.N., and Roth J.A. Hum. Gene Ther. 4 (1993) 451
18. Cowsert L.M. Anti-Cancer Drug Dev. 12 (1997) 359
19. Kita K., Saito S., Morikawa C.Y., and Watanabe A. Int. J. Cancer 80 (1999) 554
20. Andreyev H.J.N., Ross P.J., Cunningham D., and Clarke P.A. Gut 48 (2001) 230
21. Cimino G.D., Gamper H.B., Isaacs S., and Hearst J. Annu. Rev. Biochem. 54 (1985) 1151
22. Lee B.L., Murakami A., Blake K.R., Lin S.B., and Miller P.S. Biochemistry 27 (1988) 3197
23. Kean J.M., Murakami A., Blake K.R., Cushman C.D., and Miller P.S. Biochemistry 27 (1988) 9113
24. Murakami A., Yamayoshi A., Iwase R., Nishida J., Yamaoka T., and Wake N. Eur. J. Pharm. Sci. 13 (2001) 25
25. Yamayoshi A., Kato K., Suga S., Ichinoe A., Arima T., Matsuda T., Kato H., Murakami A., and Wake N. Oligonucleotide 17 (2007) 66
26. Higuchi M., Yamayoshi A., Yamaguchi T., Iwase R., Yamaoka T., and Murakami A. Nucleosides, Nucleotides Nucleic Acids 26 (2007) 277
27. Stary A., and Sarasin A. Methods Enzymol. 319 (2000) 153165
28. McDonald D.Q., and Still W.C. Tetrahedron Lett. 33 (1992) 7743
29. Mohamadi F., Richards N.G.J., Guida W.C., Liskamp R., Lipton M., Canfield C., Chang G., Hendrickson T., and Still W.C. J. Comput. Chem. 11 (1990) 440
30. Isaacs S.T., Shen C.J., Hearst J.E., and Rapoport H. Biochemistry 16 (1977) 1058
31. Pieles U., and Englisch U. Nucleic Acids Res. 17 (1989) 285
32. Ti G.S., Gaffney B.L., and Jones R.A. J. Am. Chem. Soc. 104 (1982) 1316
33. Salet C., De Sa E Melo T.M., Bensasson R., and Land E.J. Biochem. Biophys. Acta 607 (1980) 379
34. Rabin D., and Crothers D.M. Nucleic Acids Res. 7 (1979) 689